SCHEMBL6505248

SCHEMBL6505248

Cc1cc(C)c(-c2c3nc(c(-c4cc(C(C)(C)C)cc(C(C)(C)C)c4)c4ccc(cc5nc(c(-c6cc(C(C)(C)C)cc(C(C)(C)C)c6)c6ccc2[nH]6)C=C5)[nH]4)C=C3)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.48
▸ STAT1 P42224 1/20 0.48
▸ TERT O14746 4/20 0.36
▸ TOP1 P11387 4/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ CYCS P99999 3/20 0.32
▸ ENPP2 Q13822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260277 0.91 STAT3 (0.56) STAT3STAT1TERTTOP1ABCG2
SCHEMBL4261963 0.90 STAT3 (0.55) STAT3STAT1TERTTOP1ABCG2
SCHEMBL12987775 0.89 STAT3 (0.59) STAT3STAT1TERTTOP1ABCG2
SCHEMBL93007 0.88 STAT3 (0.56) STAT3STAT1TERTTOP1ABCG2
SCHEMBL31127548 0.88 STAT3 (0.58) STAT3STAT1TERTTOP1ABCG2
SCHEMBL227423 0.88 STAT3 (0.54) STAT3STAT1TERTTOP1ABCG2
SCHEMBL31127544 0.88 STAT3 (0.58) STAT3STAT1TERTTOP1ABCG2
SCHEMBL30527240 0.86 STAT3 (0.67) STAT3STAT1TERTTOP1ABCG2
SCHEMBL78903 0.85 STAT3 (0.56) STAT3STAT1TERTTOP1ABCG2
SCHEMBL30527241 0.85 STAT3 (0.66) STAT3STAT1TERTTOP1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6849730-B2 Methods of making porphyrins and related compounds with Lewis acids NORTH CAROLINA STATE UNIVERSITY (US) 2005-02-01 — — US disclosed
US-20030096978-A1 Methods of making porphyrins and related compounds with Lewis acids NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096978-A1 Methods of making porphyrins and related compounds with Lewis acids DDT, LIG3, SHARPIN STAT3 3690/4885STAT1 4534/4885TERT 374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback